Skip to main content
Hit enter to search or ESC to close
Close Search
search
Menu
Home
About Us
About Us
To become most Valued & Trusted partner for access to medicines.
Our Mission
Menu
Vision and Mission
Management Team
Partnership
Corporate Values
Gallery
How can we help
How can we help
Any question or remarks? Just write us a message!
Contact Us
Menu
Patients & Healthcare Professionals
Pharmaceutical Companies
Services
Services
To become most Valued & Trusted partner for access to medicines.
Services Overview
Services Menu
RLD Supplies
Clinical Trial Material supplies
Unregistered medicines Import Services
Rare Diseases Products Access
Global footprints
Global footprints
To become most Valued & Trusted partner for access to medicines.
Menu
Global Network Offices
Warehousing and Logistics
All Resources
twitter
facebook
linkedin
youtube
instagram
Contact Us
search
All Resources
All Resources
Events
Latest Approval
News
Filter
All
All Resources
Events
Latest Approval
News
All Resources
News
Fda approves wezlana as an interchangeable biosimilar to stelara for Multiple Inflammatory Diseases
The US Food and Drug Administration (FDA) has approved Wezlana (ustekinumab-auub) as…
Read More
All Resources
Events
Navigating the Future of the Healthcare Industry: Insights into CPhI Europe
The healthcare sector has been brought to the forefront of global innovation…
Read More
All Resources
Latest Approval
FDA approves Sandoz Tyruko for the treatment of multiple sclerosis
Tyruko (natalizumab-site), a natalizumab biosimilar, has been authorized by the FDA as…
Read More
All Resources
News
Horizon Therapeutics takes the rare disease reputation crown
Another wreath has been added to Horizon Therapeutics' pre-takeover victory lap. Months…
Read More
All Resources
Latest Approval
FDA Approves Breakthrough Treatment for CHAPLE Disease
FDA has recently approved the first-ever treatment for pancreatitis, a protein-loss form…
Read More
All Resources
Events
INVIMEDS HEALTH TO PRESENT INNOVATIONS AT EXPOPHARM 2023, DUSSELDORF
A prominent role player in the pharmaceutical and healthcare industry, InviMeds Health…
Read More
All Resources
Events
A Successful Collaboration: InviMeds Health Shines at ARAB HEALTH 2023
InviMeds Health a leading healthcare company is proud to announce its successful…
Read More
Filter
Events
All Resources
Events
Navigating the Future of the Healthcare Industry: Insights into CPhI Europe
The healthcare sector has been brought to the forefront of global innovation…
Read More
All Resources
Events
INVIMEDS HEALTH TO PRESENT INNOVATIONS AT EXPOPHARM 2023, DUSSELDORF
A prominent role player in the pharmaceutical and healthcare industry, InviMeds Health…
Read More
All Resources
Events
A Successful Collaboration: InviMeds Health Shines at ARAB HEALTH 2023
InviMeds Health a leading healthcare company is proud to announce its successful…
Read More
Filter
Latest Approval
All Resources
Latest Approval
FDA approves Sandoz Tyruko for the treatment of multiple sclerosis
Tyruko (natalizumab-site), a natalizumab biosimilar, has been authorized by the FDA as…
Read More
All Resources
Latest Approval
FDA Approves Breakthrough Treatment for CHAPLE Disease
FDA has recently approved the first-ever treatment for pancreatitis, a protein-loss form…
Read More
Filter
News
All Resources
News
Fda approves wezlana as an interchangeable biosimilar to stelara for Multiple Inflammatory Diseases
The US Food and Drug Administration (FDA) has approved Wezlana (ustekinumab-auub) as…
Read More
All Resources
News
Horizon Therapeutics takes the rare disease reputation crown
Another wreath has been added to Horizon Therapeutics' pre-takeover victory lap. Months…
Read More
Close Menu
Home
About Us
About Us
To become most Valued & Trusted partner for access to medicines.
Our Mission
Menu
Vision and Mission
Management Team
Partnership
Corporate Values
Gallery
How can we help
How can we help
Any question or remarks? Just write us a message!
Contact Us
Menu
Patients & Healthcare Professionals
Pharmaceutical Companies
Services
Services
To become most Valued & Trusted partner for access to medicines.
Services Overview
Services Menu
RLD Supplies
Clinical Trial Material supplies
Unregistered medicines Import Services
Rare Diseases Products Access
Global footprints
Global footprints
To become most Valued & Trusted partner for access to medicines.
Menu
Global Network Offices
Warehousing and Logistics
All Resources
Contact Us
+91 96508 77511
enquiry@invimeds.com
twitter
facebook
linkedin
youtube
instagram